Want to see HK:8158 full AI Analyst Report?
China Regenerative Medicine International Limited (8158) Financial Statements
0 Followers
China Regenerative Medicine International Limited Financial Overview
China Regenerative Medicine International Limited's market cap is currently HK$73.02M. The company's EPS TTM is HK$0.10; its P/E ratio is 2.44; China Regenerative Medicine International Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 72.06M | HK$ 90.62M | HK$ 69.49M | HK$ 41.54M | HK$ 282.90M |
| Gross Profit | HK$ 41.92M | HK$ 57.65M | HK$ 19.42M | HK$ 37.62M | HK$ 67.73M |
| Operating Income | HK$ -1.59M | HK$ 18.88M | HK$ -109.11M | HK$ 12.29M | HK$ 58.96M |
| EBITDA | HK$ 8.26M | HK$ 29.84M | HK$ -95.40M | HK$ 9.92M | HK$ 65.11M |
| Net Income | HK$ 27.52M | HK$ 17.75M | HK$ -107.70M | HK$ 4.55M | HK$ 51.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 8.17M | HK$ 57.45M | HK$ 3.33M | HK$ 1.85M | HK$ 9.93M |
| Total Assets | HK$ 168.06M | HK$ 135.71M | HK$ 185.90M | HK$ 275.91M | HK$ 259.14M |
| Total Debt | HK$ 51.31M | HK$ 53.69M | HK$ 50.19M | HK$ 72.01M | HK$ 35.82M |
| Net Debt | HK$ 43.14M | HK$ 30.99M | HK$ 46.86M | HK$ 70.16M | HK$ 25.89M |
| Total Liabilities | HK$ 114.58M | HK$ 110.51M | HK$ 174.10M | HK$ 172.00M | HK$ 147.41M |
| Stockholders' Equity | HK$ 53.47M | HK$ 25.20M | HK$ 11.79M | HK$ 103.92M | HK$ 111.73M |
| Cash Flow | |||||
| Free Cash Flow | HK$ 4.03M | HK$ 17.68M | HK$ 6.06M | HK$ -20.25M | HK$ -3.83M |
| Operating Cash Flow | HK$ 4.10M | HK$ 18.30M | HK$ 6.34M | HK$ -17.65M | HK$ -3.02M |
| Investing Cash Flow | HK$ -70.00K | HK$ -622.00K | HK$ -262.00K | HK$ -2.59M | HK$ 9.27M |
| Financing Cash Flow | HK$ -19.11M | HK$ 2.37M | HK$ -7.36M | HK$ 7.32M | HK$ -1.39M |
Currency in HKD
